Nuwellis (NASDAQ:NUWE) Releases Earnings Results, Beats Expectations By $2.62 EPS

Nuwellis (NASDAQ:NUWE) released its earnings results on Monday. The company reported $1.74 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.88) by $2.62, Zacks reports. The company had revenue of $2.37 million during the quarter, compared to analyst estimates of $2.40 million. Nuwellis had a negative return on equity of 1,716.60% and a negative net margin of 169.54%. During the same quarter in the prior year, the company earned ($63.29) earnings per share.

Nuwellis Stock Down 5.9 %

Shares of NASDAQ:NUWE opened at $1.93 on Wednesday. Nuwellis has a fifty-two week low of $1.00 and a fifty-two week high of $31.15. The business has a 50-day moving average of $1.52 and a two-hundred day moving average of $3.92.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on the company. Roth Mkm restated a “buy” rating and issued a $17.00 target price on shares of Nuwellis in a report on Tuesday, August 13th. Roth Capital upgraded Nuwellis to a “strong-buy” rating in a report on Monday, July 29th.

Nuwellis Company Profile

Nuwellis, Inc, a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter.